| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/20/2005 | EP1523498A1 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
| 04/20/2005 | EP1523497A2 HSP70 FROM i ARTHROBACTER /i |
| 04/20/2005 | EP1523496A2 Recombinant production of mixtures of antibodies |
| 04/20/2005 | EP1523495A2 Peptides for inducing apoptosis in tumor cells |
| 04/20/2005 | EP1523494A2 Beta-sheet forming peptides and material made thereof |
| 04/20/2005 | EP1523492A2 Igg fc/hiv-gp120/c3d fusion protein |
| 04/20/2005 | EP1523491A2 Maize clavata3-like polynucleotide sequences and methods of use |
| 04/20/2005 | EP1523372A2 Ghrelin-carrier conjugates |
| 04/20/2005 | EP1523336A1 Targeted agents for nerve regeneration |
| 04/20/2005 | EP1523334A2 Hapten-carrier conjugates and uses thereof |
| 04/20/2005 | EP1523333A2 Use of vaccinia virus deleted for the e3l gene as a vaccine vector |
| 04/20/2005 | EP1523331A2 Therapeutic tb vaccine |
| 04/20/2005 | EP1523329A2 Adjuvant viral particle |
| 04/20/2005 | EP1523326A2 Insulin-associated peptides with effects on cerebral health |
| 04/20/2005 | EP1523325A2 Methods and compositions for treating polycystic ovary syndrome |
| 04/20/2005 | EP1523323A2 Reagents and methods for smooth muscle therapies |
| 04/20/2005 | EP1523322A2 Novel proteins and nucleic acids encoding same |
| 04/20/2005 | EP1523308A2 Phenylthiocarbamide (ptc) taste receptor |
| 04/20/2005 | EP1436324A4 Gene controlling life span of leaves in plants and method for controlling life span of plants using the gene |
| 04/20/2005 | EP1397511A4 Genetic markers for improved disease resistance in animals (bip) |
| 04/20/2005 | EP1297113A4 Cyanobacterial nucleic acid fragments encoding proteins useful for controlling plant traits via nuclear or plastome transformation |
| 04/20/2005 | EP1292712A4 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 04/20/2005 | EP1206547B1 Moraxella catarrhalis antigen basb117 |
| 04/20/2005 | EP1206546B1 Moraxella catarrhalis antigen basb120 |
| 04/20/2005 | EP1196184B1 Compositions for treatment of sexual dysfunction |
| 04/20/2005 | EP1185649B1 The myostatin gene promoter and inhibition of activation thereof |
| 04/20/2005 | EP1175435B1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof |
| 04/20/2005 | EP1135506B1 Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
| 04/20/2005 | EP1068226B1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination |
| 04/20/2005 | EP1041890B1 Carbohydrate oxidase and use thereof in baking |
| 04/20/2005 | EP1009753B1 Hypoxia-regulated genes |
| 04/20/2005 | EP0956303B1 Non-naturally occurring lipoprotein particle |
| 04/20/2005 | EP0917471B1 Treatment and diagnosis of infections of gram positive cocci |
| 04/20/2005 | EP0871704B1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 04/20/2005 | EP0835301B1 Monoclonal antibody directed against rat beta 2 integrin alpha d subunit and corresponding hybridoma |
| 04/20/2005 | EP0831886B1 Thrombopoietin compositions |
| 04/20/2005 | EP0813604B1 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
| 04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 04/20/2005 | EP0759995B1 Fusion glycoprotein from hcmv and hsv |
| 04/20/2005 | EP0700430B1 Methods for selectively stimulating proliferation of t cells |
| 04/20/2005 | CN1608135A Methods and compositions for inducing tumor-specific cytotoxicity |
| 04/20/2005 | CN1608133A Use of a double-stranded ribonucleic acid for treating an infection with a positivestrand rna-virus |
| 04/20/2005 | CN1608129A Alkaline protease from bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease |
| 04/20/2005 | CN1608079A Chemically-modified human growth hormone conjugates |
| 04/20/2005 | CN1608078A Gonadotrophins for folliculogenesis |
| 04/20/2005 | CN1607957A Modulation of excitable tissue function by peripherally administered erythropoietin |
| 04/20/2005 | CN1607253A Fermentative carotenoid production |
| 04/20/2005 | CN1607209A Poly thymosin-alpha 1, its composition, its preparation method and application |
| 04/20/2005 | CN1607208A Method for acquiring amino acid sequence of effective constituent of traditional Chinese medicine and the specific amino acid sequence determined by the method |
| 04/20/2005 | CN1607207A S protein of SARS virus, its vaccine and method for screening medicament using it |
| 04/20/2005 | CN1607005A Soluble lymphotoxin- beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 04/20/2005 | CN1607004A Recombinant foot-and-mouth disease virus VP1 confluent protein vaccine |
| 04/20/2005 | CN1197970C Sugarcane bacilliform virus promoter |
| 04/20/2005 | CN1197968C Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 04/20/2005 | CN1197966C Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 04/20/2005 | CN1197964C Directed evolution of microorganisms |
| 04/20/2005 | CN1197961C BHV-1 gene-deleted virus vaccine |
| 04/20/2005 | CN1197876C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 04/20/2005 | CN1197875C Process for purifying hematoglobin |
| 04/20/2005 | CN1197874C Modification and preparation of human interleukin 11 |
| 04/20/2005 | CN1197873C Human connective tissue growing factor and its preparing method |
| 04/20/2005 | CN1197872C Polypeptide with alpha-galactosidase activity and its coding nucleic acid |
| 04/20/2005 | CN1197618C Mutant cholera holotoxin as an adjuvant |
| 04/19/2005 | US6881877 Enhanced accumulation of trehalose in plants |
| 04/19/2005 | US6881834 Myeloid cell promoter and constructs containing same |
| 04/19/2005 | US6881833 Component in the hedgehog signalling pathway |
| 04/19/2005 | US6881832 Comprises nucleotide sequences coding signal sequences for transport of heterologous proteins into preferential cellular compartments |
| 04/19/2005 | US6881828 Chimeric polypeptide for developing vaccines for treatment of viral and tumor diseases |
| 04/19/2005 | US6881827 Molecular cloning of a 7TM receptor (AXOR34) and screening methods thereof |
| 04/19/2005 | US6881826 Comprises receptor which binds compounds such as clonidine and idazoxan for identifying modulators of nervous system activity |
| 04/19/2005 | US6881824 Peptides suitable for use in antigen specific immunosuppressive therapy |
| 04/19/2005 | US6881823 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing |
| 04/19/2005 | US6881822 Antibody for use in the treatment of tumors |
| 04/19/2005 | US6881821 Hepatitis-C virus type 4, 5, and 6 |
| 04/19/2005 | US6881789 A biopolymer containing a mixture of ubiquitin and at least one cross-linking agent which is selected from photoreactive or thermoreactive crosslinker |
| 04/19/2005 | US6881720 Antimicrobial protein from Lyophyllum shimeji |
| 04/19/2005 | US6881718 Discovery of novel disulfide linked cell toxins which can ablate NK-1 receptor expressing cells. These toxins are used as pharmaceutical compositions for the ablation of NK1 receptor expressing cells and comprise a substance P |
| 04/19/2005 | US6881577 DNA-peptide-lipid complex for enhancing gene transfer into cells; cationic liposomes |
| 04/19/2005 | US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents |
| 04/19/2005 | US6881555 AKT nucleic acids, polypeptides, and uses thereof |
| 04/19/2005 | US6881552 Human protease associated proteins |
| 04/19/2005 | US6881548 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 04/19/2005 | US6881546 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 04/19/2005 | US6881545 Identifying modulators of human pituitary and/or mouse ligand polypeptide binding for treatment and prevention of nervous system, cancer, diabetic, hypercholesterolemic, pancreatic and inflammatory disorders |
| 04/19/2005 | US6881411 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 04/19/2005 | US6881410 Treatment of E. faecium infection |
| 04/19/2005 | US6881401 Methods of treatment of immune system related disorders using Neutrokine-alpha |
| 04/19/2005 | US6881395 Ligand for use as tool in the treatment of tumors in humans |
| 04/19/2005 | CA2265252C Angiogenic factor and use thereof in treating cardiovascular disease |
| 04/19/2005 | CA2139507C Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 04/19/2005 | CA2059137C Enhancement of musculature in animals |
| 04/16/2005 | CA2484648A1 High strength and lubricious materials for vascular grafts |
| 04/16/2005 | CA2480199A1 Fp-ghrelin |
| 04/14/2005 | WO2005033343A2 Novel splice variants of human dkkl1 |
| 04/14/2005 | WO2005033325A1 Method of producing a recombinant polypeptide free of o-linked mannose residues |
| 04/14/2005 | WO2005033321A2 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/14/2005 | WO2005033320A1 Packaging cells for recombinant adenovirus |
| 04/14/2005 | WO2005033317A1 Chimeric carrier molecules for the production of mucosal vaccines |
| 04/14/2005 | WO2005033312A1 C1q related protein |
| 04/14/2005 | WO2005033311A2 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |